Sexual Health Counseling Based on the BETTER Model

Sponsor
Lokman Hekim Üniversitesi (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05796180
Collaborator
(none)
70
1
2
7
10

Study Details

Study Description

Brief Summary

In this study, the investigators wanted to examine the effect of sexual health counseling to women in the postpartum period on the quality of life of the participants.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral: sexual health counseling based on the BETTER model
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Sexual Health Counseling Based on the BETTER Model on Postpartum Sexual Life Quality: A Randomized Controlled Study
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral: sexual health counseling based on the BETTER model

Sexual health counseling based on the BETTER model The content of the research will be discussed by face-to-face interviews with women who gave birth vaginally and applied to the hospital for birth control 8-10 weeks after delivery. Pre-evaluation forms will be applied to women who have agreed to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. An appointment will be made for interviews with the women in the experimental group. It is planned that these meetings will be held in the form of online video calls and will last an average of 45 minutes. The final tests will be held 4 weeks after the online meetings are over.

Behavioral: Behavioral: sexual health counseling based on the BETTER model
The content of the research will be discussed by face-to-face interviews with women who gave birth vaginally and applied to the hospital for birth control 8-10 weeks after delivery. Pre-evaluation forms will be applied to women who have agreed to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. An appointment will be made for interviews with the women in the experimental group. It is planned that these meetings will be held in the form of online video calls and will last an average of 45 minutes. The final tests will be held 4 weeks after the online meetings are over.

No Intervention: Control group: Routine postpartum care

Routine postpartum care Women who gave birth vaginally and applied to the hospital for postpartum controls 8-10 weeks after delivery will be interviewed face-to-face with the women and the content of the research will be mentioned. Pre-evaluation forms will be applied to the women who accepted to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. Women in the control group will receive routine postpartum care administered in the hospital. Women in the control group will receive routine postpartum care administered in the hospital. Post-tests will be administered 8 weeks after the first interview.

Outcome Measures

Primary Outcome Measures

  1. Postpartum Sexual Life Quality [8 week]

    The scale is still under development.

  2. Arizona Sexual Experiences Scale [8 week]

    The Arizona Sexual Experiences Scale (ASEX) is a 6-point Likert-type self-report scale and consists of 5 questions. This form reveals the capacity to reach orgasm, the feeling of satisfaction, vaginal wetness, arousal and sexual drive. Each question is scored from 1 to 6. The total score ranges from 5 to 30. Low scores indicate that the sexual response is satisfactory, strong and easy, while high scores indicate the presence of sexual dysfunction. The total scale score is formed by the sum of the scores of the scale items in the scale. The cut-off point of the scale was determined as 11. A score of 5 or more for each item indicates that there is a sexual dysfunction related to that item.

  3. Female Sexual Satisfaction Scale [8 week]

    The scale has 24 sub-dimensions of satisfaction, communication, agreeableness, personal concern and relational concern and consists of 30 items. In 29 items, a 5-point Likert scale ranging from "strongly disagree" to "strongly agree" is used. For one item, a 5-point Likert scale ranging from "totally satisfactory" to "not at all satisfactory" is used. Average scores are calculated for each subscale. Higher scores are interpreted as more sexual satisfaction. For each sub-dimension in the scale, the lowest score is 6.0 and the highest score is 30.0. Total Score = Satisfaction + Communication + Compliance + (Relational Worry + Personal Worry) /2 formula is used to calculate the total score of the scale. Accordingly, the lowest score that can be obtained from the scale is 24.0, and the highest score is 120.0.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Primiparous,

  • Have had a vaginal birth,

  • Without a diagnosed chronic disease (DM, HT, Heart disease, etc.),

  • 18 years or older,

  • Able to speak and understand Turkish,

Exclusion Criteria:

• Edinburgh Postpartum Depression Scale score of 12 and above,

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lokman Hekim Etlik Hospital Ankara Keçiören Turkey

Sponsors and Collaborators

  • Lokman Hekim Üniversitesi

Investigators

  • Study Director: Nurgül ŞİMAL YAVUZ, Lecturer, Lokman Hekim Üniversitesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nurgül ŞİMAL YAVUZ, Lecturer, Lokman Hekim Üniversitesi
ClinicalTrials.gov Identifier:
NCT05796180
Other Study ID Numbers:
  • NSIMALYAVUZ
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nurgül ŞİMAL YAVUZ, Lecturer, Lokman Hekim Üniversitesi

Study Results

No Results Posted as of Apr 3, 2023